Ask any three otherwise healthy cardiologists whether they are taking a cholesterol-lowering drug, and chances are good that at least two of them will reply with a hearty "You bet." Their prescription of choice: one of a group of drugs called statins--marketed under such names as Lipitor, Pravachol and Zocor--that have been proved to reduce deaths among heart-attack survivors by more than 40% over five years. In effect, the doctors are taking a highly educated gamble that the medications, currently taken by more than 10 million Americans, will be just as effective in those who do not necessarily fit the profile...
To continue reading:
or
Log-In
